Journal of Applied Physiology Millar Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 91: 847-858, 2001;
8750-7587/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wetter, T. J.
Right arrow Articles by Dempsey, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wetter, T. J.
Right arrow Articles by Dempsey, J. A.
Vol. 91, Issue 2, 847-858, August 2001

Effects of exhaustive endurance exercise on pulmonary gas exchange and airway function in women

Thomas J. Wetter, Claudette M. St. Croix, David F. Pegelow, David A. Sonetti, and Jerome A. Dempsey

Department of Preventive Medicine, John Rankin Laboratory of Pulmonary Medicine, University of Wisconsin, Madison, Wisconsin 53705


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Seventeen fit women ran to exhaustion (14 ± 4 min) at a constant speed and grade, reaching 95 ± 3% of maximal O2 consumption. Pre- and postexercise lung function, including airway resistance [total respiratory resistance (Rrs)] across a range of oscillation frequencies, was measured, and, on a separate day, airway reactivity was assessed via methacholine challenge. Arterial O2 saturation decreased from 97.6 ± 0.5% at rest to 95.1 ± 1.9% at 1 min and to 92.5 ± 2.6% at exhaustion. Alveolar-arterial O2 difference (A-aDO2) widened to 27 ± 7 Torr after 1 min and was maintained at this level until exhaustion. Arterial PO2 (PaO2) fell to 80 ± 8 Torr at 1 min and then increased to 86 ± 9 Torr at exhaustion. This increase in PaO2 over the exercise duration occurred due to a hyperventilation-induced increase in alveolar PO2 in the presence of a constant A-aDO2. Arterial O2 saturation fell with time because of increasing temperature (+2.6 ± 0.5°C) and progressive metabolic acidosis (arterial pH: 7.39 ± 0.04 at 1 min to 7.26 ± 0.07 at exhaustion). Plasma histamine increased throughout exercise but was inversely correlated with the fall in PaO2 at end exercise. Neither pre- nor postexercise Rrs, frequency dependence of Rrs, nor diffusing capacity for CO correlated with the exercise A-aDO2 or PaO2. Although several subjects had a positive or borderline hyperresponsiveness to methacholine, this reactivity did not correlate with exercise-induced changes in Rrs or exercise-induced arterial hypoxemia. In conclusion, regardless of the degree of exercise-induced arterial hypoxemia at the onset of high-intensity exercise, prolonging exercise to exhaustion had no further deleterious effects on A-aDO2, and the degree of gas exchange impairment was not related to individual differences in small or large airway function or reactivity.

exercise-induced arterial hypoxemia; arterial blood gases; esophageal temperature; respiratory resistance; histamine


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

EXERCISE-INDUCED ARTERIAL hypoxemia (EIAH), defined as an inability to maintain resting levels of arterial O2 partial pressure (PaO2) and arterial O2 saturation (SaO2) of Hb, occurs in many trained subjects during incremental exercise tests to maximum (13, 18, 37). This condition is primarily due to an excessive alveolar-to-arterial O2 difference (A-aDO2) and inadequate compensatory hyperventilation but also to increasing temperature and metabolic acidosis, which cause a rightward shift in the Hb-O2 dissociation curve (14). In susceptible individuals, during brief, high-intensity exercise, PaO2 falls in the first minute of exercise and stays relatively constant over the ensuing 2-4 min, whereas, at the same time, %SaO2 continues to fall as pH decreases (13, 21, 32). Furthermore, EIAH begins to occur even in submaximal exercise in some subjects and often worsens as work rate is further increased (13, 18, 40). During long-term, high-intensity exercise, these influences on pulmonary gas exchange might be altered. For example, in moderate-intensity [65% maximum O2 consumption (VO2 max)], prolonged exercise, ventilation-perfusion (VA/Q) inequality was shown to increase with time, and although A-aDO2 did not widen much beyond resting levels and did not worsen over time in this study (20), this might not be the case in higher intensity endurance exercise. On the other hand, EIAH may be lessened in prolonged exercise because hyperventilation is progressive and arterial pH may remain near normal or actually shift in an alkaline direction over time (17).

Airway inflammation and narrowing, leading to abnormal ventilation distribution, could contribute to the widened A-aDO2 seen during incremental exercise. The condition of asthma is characterized by some degree of airway inflammation, and high rates of ventilation result in a drying of airway mucosal cells and can lead to increases in bronchoconstrictor mediator release (8). Whereas asthmatic subjects typically respond to exercise with large and small airway constriction, perhaps in subjects with EIAH the large airways are protected from bronchoconstriction but smaller peripheral airways are not. Histamine is one inflammatory mediator that has been shown to increase during heavy exercise and that could cause bronchoconstriction at the level of the small airways and/or increase microvascular permeability (2). Both factors could contribute to gas exchange abnormalities. In addition, increases in peripheral airway resistance could constrain ventilation and contribute to the inadequate alveolar hyperventilation seen in subjects with EIAH. The differences in susceptibility to EIAH among fit subjects may also be related to differences in airway smooth muscle reactivity. To date, a role for exercise-induced changes in airway resistance has not been evident, as decreases in the maximal flow-volume loop after maximal exercise have not been demonstrated in subjects with EIAH (23). However, this does not rule out a significant role for increased airway reactivity, inflammation, and narrowing of the smaller airways in EIAH (26).

We were interested in the effects of prolonged, constant-speed, high-intensity exercise to exhaustion on EIAH and its components, as this type of exercise bout is more typical of a racelike situation than a progressive, incremental exercise test. We also wondered whether changes in large or small airway resistance or interindividual differences in resting (preexercise) airway resistance or airway reactivity might be implicated as causes of an excessively widened A-aDO2. We, therefore, characterized the development of EIAH and its components over the course of a ~15-min constant-speed treadmill exercise bout to exhaustion (mean of 93% VO2 max) in fit women runners. We also compared pre- with postexercise changes in lung function, including total respiratory resistance (Rrs) at 5-35 Hz and general airway reactivity to methacholine challenge, with the degree of gas exchange impairment. We hypothesized that EIAH, especially during prolonged, high-intensity exercise, would in part be due to enhanced airway reactivity and exercise-induced changes in airway caliber and resistance.

We used women as our test subjects because 1) less exercise data, including blood-gas data, have been collected in women; 2) EIAH has been observed in some active women with a much lower absolute VO2 max than in men with EIAH, and some of these women show significant EIAH even during submaximal exercise, possibly due to smaller relative lung and airway size (18, 27, 29); 3) there is some epidemiological evidence that women have greater general airway reactivity compared with men (35, 47).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects. Seventeen healthy women (nonsmoking) were recruited to participate in this study. Informed consent was obtained in writing from each subject, and all procedures were approved by the Institutional Review Board of the University of Wisconsin-Madison. All subjects were nonelite runners; however, most competed in local road races. Fourteen considered running their primary physical activity, two were cyclists, and one was a triathlete. Nine of the subjects were on oral contraceptives, and the other eight were tested during the follicular phase of their menstrual cycle. Based on a detailed questionnaire, all subjects were free from cardiopulmonary disease. Two subjects had used bronchodilators (last usage was >2 mo before the study); however, at the time of the study, none was taking medication with the exception of one subject taking allergy medication.

Resting pulmonary function tests. Vital capacity (VC), inspiratory capacity (IC), forced expiratory volume in 1 s (FEV1), functional residual capacity, and total lung capacity (TLC) were determined as previously reported (28). Lung diffusing capacity for carbon monoxide (DLCO) and residual volume were determined by a single-breath, breath-holding technique (33). Briefly, seated subjects made a maximal inspiration from residual volume of a gas mixture containing 20.9% O2, 0.5% Ne, 0.4% CO, balance N2. The breath was held for 10 s and then expired. The first liter of expired gas was discarded, then ~50% of the VC was collected, and Ne and CO concentration was analyzed by gas chromatograph. Measurements were made in triplicate, separated by 5 min, and the average value was recorded. Closing volume was measured by using a standard single-breath N2 washout procedure (42). Total Rrs was measured by using the forced oscillation technique (Jaeger, MS-IOS), and both room air (all subjects) and helium (11 subjects) were used as the inspired gas (9). Frequency dependence of resistance (Rrs, 5-25 Hz) was calculated as the change in Rrs from 5 to 25 Hz, and resonant frequency was the frequency at which reactance equaled zero. In 13 of the subjects, exhaled nitric oxide (NO) concentration was measured at a constant expiratory airflow rate, as previously described (45). These tests were all performed both before and after exercise.

Exercise protocols. Subjects breathed through a low-resistance, two-way valve (model 2400; Hans Rudolph, Kansas City, MO), and expired gases were sampled at the mouth and after a 8.64-liter mixing chamber via a Perkin-Elmer (Norwalk, CT) mass spectrometer (model 1100). Inspiratory and expiratory flow rates were measured separately by heated pneumotachographs (23). Signals were displayed on a chart recorder, sent through an analog-to-digital board, and sampled on a computer at 75 Hz. Subjects wore a heart rate monitor (Polar Electro, Kempele, Finland).

Initially, subjects completed an incremental VO2 max exercise test on a treadmill. At a later date, a second treadmill test was conducted at a constant speed and a slight grade, which combined to elicit ~90-95% VO2 max and could be sustained for ~15 min. DLCO tests were conducted on this day both pre- and ~30 min postexercise. This treadmill test served to familiarize the subjects with the exercise protocol to be conducted while drawing arterial blood. The exercise protocol on the day of blood collection (third exercise test) is depicted in Fig. 1. A 20-gauge arterial catheter (Arrow) was inserted percutaneously in the radial artery of the left arm under local 1% lidocaine anesthesia, and a Mon-a-therm nasopharyngeal temperature probe (Mallinckrodt Medical, St. Louis, MO) was placed intranasally in the lower one-third of the esophageal lumen. After preexercise lung function tests, resting arterial blood samples were collected while subjects breathed on the mouthpiece. After a brief warmup, subjects ran for 3 min at 50 and 75% VO2 max, and blood samples were collected during the final 30 s of each workload. The speed and grade of the treadmill were then increased over 30 s to the predetermined high-intensity (~90% VO2 max) constant work rate (speed 8.0 ± 0.5 mph, grade 2.6 ± 0.8%). Subjects were instructed and encouraged to run as long as possible. Arterial blood was collected every 2 min beginning at minute 1 and also at exhaustion (minutes 1, 3, 5, ... , final 30 s of exercise). After an ~30-min rest, during which time postexercise pulmonary function tests were performed, subjects again ran for 3 min at the same constant ~90% workload, after which time the grade was increased by 2-4% to bring the subjects to VO2 max, and they ran until exhaustion (time at final workload = 95 ± 30 s).


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   Exercise protocol used on day of arterial blood collection. Subject preparation involved insertion of arterial catheter, esophageal temperature probe, and preexercise lung function tests. Pre- and postexercise lung function tests included maximal flow-volume loops (conducted 5 ± 2 min postexercise), constant-flow nitric oxide, airway resistance measures with air and helium (10 ± 2 min), single-breath nitrogen washout (20 ± 6 min), and diffusing capacity for carbon monoxide (~30 min). Nos. in shaded blocks denote the duration of each exercise bout (in min). VO2 max, maximum O2 consumption.

On the day of blood collection, ambient temperature was 23 ± 1°C, barometric pressure was 732 ± 5 mmHg, and a 16-in. fan cooled subjects during the exercise bout.

Blood gas, body temperature, blood lactate, and plasma histamine measurements. Samples (3-5 ml) of arterial blood were drawn anerobically over 10-20 s during each trial for measurement of PO2, PCO2, and pH with a blood-gas analyzer calibrated with tonometered blood (ABL300, Radiometer), and samples of O2 saturation and Hb were measured with a CO-oximeter (OSM 3, Radiometer). Calculated SaO2 values (based on measured PaO2 and changes in body temperature and pH) were essentially identical to measured SaO2 [r = 0.96; where calculated SaO2 = 0.998 (CO-oximeter %SaO2) + 0.048]. Blood gases were corrected for body temperature changes during exercise. The alveolar O2 partial pressure (PAO2) was estimated by using the ideal alveolar gas equation (34). Blood lactate concentration was analyzed by means of a Yellow Springs Instruments lactate analyzer (model 1500 Sport). Hematocrit was determined by microcentrifuge. Blood samples for histamine were drawn into tubes with EDTA and immediately placed on ice until centrifugation. Plasma was harvested and stored at -70°C until analysis with an enzyme immunoassay kit (Immunotech, Marseille, France).

Methacholine challenge test. A methacholine challenge test (MCT) was done to test for an association between general airway reactivity to a bronchoconstrictor agent and exercise-induced changes in airway function or the development of EIAH or a widened A-aDO2. This test was done on a separate day in 16 of the subjects following American Thoracic Society guidelines (3). A DeVilbiss nebulizer (model 646) and Rosenthal dosimeter were used to administer methacholine chloride (Provocholine, Methapharm). A five-breath dosimeter protocol was used, and doses of saline that were 0.0625, 0.25, 1, 4, 16, and 32 mg/ml of methacholine were administered. Output of the nebulizer was 0.009 ml/breath with a 0.6-s activation. Subjects breathed in to TLC and held each breath for ~5 s. The time interval between doses was kept at 5 min. At baseline and between each dose, measures of Rrs were made first, as this method has been shown to be a more sensitive test compared with FEV1 to measure changes in bronchial tone (36, 43) and avoids a lung volume history, which might reverse a bronchoconstriction effect. This was followed by the conventional FEV1 measure and then IC measurement as an indication of the functional significance of the bronchoconstriction (i.e., changes in end-expiratory lung volume). Exhaled NO was measured last. If and when a >20% fall (from the saline dose) in FEV1 occurred, the FEV1 maneuver was repeated one to two times. If the FEV1 fell more than 20%, the dosing protocol was stopped, a bronchodilator (albuterol) administered, and tests repeated to ensure recovery from bronchoconstriction.

Statistical analysis. Subjects were divided into two groups based on the PaO2 maintained during the high-intensity prolonged exercise bout to exhaustion (the mean PaO2 value of minute 1 through the end value was calculated for each individual) and labeled according to low PaO2 (<= 80 Torr; Lo-PO2, n = 8) and high PaO2 (>80 Torr; Hi-PO2, n = 9). This categorization is similar to the >10-Torr fall in PaO2 from resting values used previously during an incremental maximal exercise test (18) but is less influenced by hyper- or hypoventilation at rest. Seven of eight subjects in Lo-PO2 and none in Hi-PO2 had a mean PaO2 decrease of >10 Torr from rest during the exercise bout. Repeated-measures two-way ANOVA was used to compare mean values for each group across time. If a main effect (group or time) or interaction (group × time) was observed, Tukey's post hoc analysis was used to determine where the differences existed. For analysis of data conducted at different exercise intensities, intensity replaced time as the factor. Linear regression was used to establish correlations. Significance was set at P < 0.05. Data are presented as means ± SD.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

General data. Subjects' physical and resting lung function characteristics are shown in Table 1. VO2 max was ~30% above predicted values, whereas DLCO was ~9% lower (P = 0.003) than predicted. Maximal voluntary ventilation in 15 s was also ~30% above predicted using a prediction equation based on age and body surface area (BSA); however, with the use of another common predictor (FEV1 × 40), this fell to 95 ± 15% of predicted.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Subject characteristics and resting pulmonary function

Prolonged exercise data. Individual and group mean data collected at rest and during the high-intensity exercise bout to exhaustion are presented in Figs. 2-4. Blood-gas data revealed a rapid fall in PaO2, a widening of A-aDO2, and a progressive decline in arterial PCO2 (PaCO2) on initiation of exercise. Throughout the duration of exercise, PaO2 increased slightly as PAO2 rose (107 ± 3 Torr at minute 1 to 112 ± 3 Torr at exhaustion), and PaCO2 fell and A-aDO2 remained relatively unchanged over the duration of the exercise. Overall mean SaO2 declined by 2.5 ± 1.9% at minute 1 and fell further throughout exercise to a nadir of 92.5 ± 2.6% at exhaustion (range 86.2-95.6%). In subjects with lower mean PaO2 values (Lo-PO2), differences in SaO2, PaO2, and A-aDO2 from Hi-PO2 were apparent early in the exercise bout (by 1-3 min), but the patterns of change over time were similar, although subjects in Lo-PO2 had a reduced rise in PaO2 from minute 1 to exhaustion. Although mean PaCO2 did not differ between groups, the decrease over time was greater in Hi-PO2 as was the increase in minute ventilation/O2 consumption (VO2).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   Individual and mean arterial blood-gas data at rest and during the ~90% VO2 max exercise bout to exhaustion. A: arterial O2 saturation (SaO2); B: arterial PO2 (PaO2); C: alveolar-arterial O2 difference (A-aDO2); and D: arterial PCO2 (PaCO2). See text for explanation of groups. , Data for Lo-PO2 group (n = 8); open circle , data for Hi-PO2 group (n = 9); both are connected by thick solid lines. For individual data, thin solid lines represent subjects in Lo-PO2 and dotted lines represent subjects in Hi-PO2. Values are means ± SD. * Significant difference between groups (P < 0.05). G, significant main effect of group; G × T, group × time significant interaction. Time effect was significant (P < 0.001) for all variables except A-aDO2 (P = 0.015).

A-aDO2 explained 93% of the variance in PaO2 (P < 0.001), whereas the correlation with PaCO2 was also significant (P = 0.017) but explained less (33%) of the variance (Fig. 5, A and B). The major differences in arterial oxygenation and gas exchange that occurred among subjects at the point of exhaustion were already present near the onset of high-intensity endurance exercise. A-aDO2 and PaO2 were not significantly correlated to VO2 max (r = 0.02, P = 0.93) in this group of runners with a narrow range of VO2 max values (44-56 ml · kg-1 · min-1).

Metabolic and heart rate data were similar between Lo-PO2 and Hi-PO2, both in terms of absolute values and changes over exercise time (Figs. 3 and 4). VO2 increased throughout the first 7 min of exercise, peaked at 95 ± 3% of VO2 max, and then remained stable until exhaustion (range 87-99% of VO2 max). VO2 did not differ between groups. CO2 production also increased from 2.46 ± 0.35 l/min at minute 1 to 2.93 ± 0.42 l/min at exhaustion. Heart rate increased from 60 ± 12 beats/min at rest to 171 ± 15 beats/min at minute 1 and 189 ± 12 beats/min at exhaustion. The increase in minute ventilation over time was due predominantly to increased breathing frequency as tidal volume reached a maximum of 51 ± 8% of VC (range 33-71%) during minute 7 before decreasing slightly over the remaining time to exhaustion.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   O2 consumption (VO2; A), minute ventilation (VE; B), and breathing frequency (bf; C) at rest and during the ~90% VO2 max exercise bout to exhaustion. Lines and symbols are as defined in Fig. 2 legend. Values are means ± SD. * Significant difference between groups (P < 0.05). Time effect was significant (P < 0.001) for all variables.



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Arterial pH (pHa; A), arterial lactate (lactatea; B), and esophageal body temperature (tempes; C) at rest and during the ~90% VO2 max exercise bout to exhaustion. Lines and symbols are as defined in Fig. 2 legend. Values are means ± SD. Time effect was significant (P < 0.001) for all variables.

Over the time of the exercise bout, pH fell progressively due to a steady but highly variable 2-8 mmol/l rise in blood lactate, which was partially compensated by the steady fall in PaCO2. Esophageal temperature was 36.9 ± 0.3°C at rest, increased to 37.3 ± 0.4°C after the warm-up period, and then increased to 37.7 ± 0.4°C at minute 1 and 39.5 ± 0.4°C at exhaustion (range 39.0-40.3°C). The pattern of temperature increase with exercise duration was similar among subjects; however, the range of absolute values was >= 1.3°C at all exercise time points.

The amount of hemoconcentration from rest to exhaustion was 1.4 ± 0.2 g/dl with the majority (1.0 ± 0.2 g/dl) occurring by minute 1 (no difference between Hi-PO2 and Lo-PO2). As a result of this and the decrease in %SaO2, arterial O2 content increased from 17.4 ± 1.5 and 18.0 ± 1.6 g/dl at rest to 18.0 ± 1.2 and 19.2 ± 1.5 g/dl at exhaustion in Lo-PO2 and Hi-PO2, respectively.

Plasma histamine was significantly increased from rest to minute 3 and further increased at end exercise (137 ± 96% above resting values). Values ranged between 2 and 8 nmol/l at exhaustion, and all returned toward resting levels during recovery (Fig. 6). The mean PaO2 maintained during exercise was positively correlated to end-exercise histamine level (Fig. 5C), and this relationship was of borderline significance (P = 0.051) when the changes in PaO2 and histamine from rest to end exercise were correlated (Fig. 5D).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 5.   Correlation between PaO2 during the ~90% VO2 max exercise bout to exhaustion and A-aDO2 (A), PaCO2 (B), and plasma histamine concentration at exhaustion (C). PaO2, A-aDO2, and PaCO2 values are mean data (mean for minute 1 to exhaustion) for each individual. Histamine values are from the sample that was collected at exhaustion. D: correlation between the fall in PaO2 from rest to end exercise and the increase in plasma histamine from rest to end exercise. Solid lines represent lines of best fit.

Causes of O2 desaturation during exercise. For the Lo-PO2 group, we partitioned the amount of the total fall in SaO2 from rest at 3 min (4.7 ± 1.8%) and at exhaustion (6.7 ± 2.7%) due to the effects of PaO2, pH, and temperature. For the initial (rest to minute 3) fall in SaO2, the 21 ± 8 Torr drop in PaO2 was the most significant factor, accounting for 65 ± 7% of the decrease in SaO2. From 3 min to end exercise, the contributions due to increasing temperature and decreasing pH accounted for the entire remaining decrease in SaO2 that occurred over time. At the end point of prolonged exercise, 54 ± 11% of the Hb-O2 desaturation from resting values was caused by the combination of metabolic acidosis (decrease of 0.14 ± 0.08 pH units) and a 2.5 ± 0.5°C rise in temperature, and the remainder (46 ± 11%) was due to a 17 ± 9 Torr decrease in PaO2.

Effects of exercise intensity on EIAH. Figure 7 shows mean SaO2, PaO2, A-aDO2, PaCO2, pH, and esophageal temperature at 3 min of exercise at 50, 75, and 90% VO2 max and during a shorter bout (95 ± 30 s) of exercise at 100% of VO2 max in Lo-PO2 and Hi-PO2 groups (categorized based on PaO2 during 90% prolonged exercise bout). The most notable findings were that, by 75% of VO2 max, PaO2 was already significantly lower and A-aDO2 wider in those subjects who showed the most EIAH during prolonged exercise (i.e., Lo-PO2 group).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Plasma histamine concentration in arterial blood at rest, during the ~90% VO2 max exercise bout to exhaustion, and during recovery. Recovery sample was collected 3.5 ± 0.7 min after the end of exercise. Lines and symbols are as defined in Fig. 2 legend. Values are means ± SD. Time effect was significant (P < 0.001).



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of exercise intensity on arterial saturation and its components. Values are means ± SD. Lo-PO2 () and Hi-PO2 (open circle ) values are shown after 3 min of work at 50 and 75% of VO2 max (before the prolonged 90% VO2 max exercise bout), at the 3-min time point during the 90% VO2 max to exhaustion trial, and at VO2 max during the repeat exercise trial. The time at VO2 max was 95 ± 30 s. The groups were categorized according to PaO2 data during the ~90% VO2 max prolonged exercise bout. * P < 0.05, compared with other group at same work rate. The effect of intensity was significant for all variables (P < 0.001).

Changes in lung function after exercise and correlation to EIAH. Pre- and postexercise lung function tests are shown in Table 2. Preexercise Rrs varied considerably among subjects (2-9 cmH2O · l-1 · s), and individual changes in Rrs after exercise were highly variable. Rrs at all frequencies fell in four subjects and was unchanged (changes of <= 1 cmH2O · l-1 · s) in the others. The higher the preexercise Rrs, the greater the fall in Rrs after exercise (r = -0.699, P = 0.002), but this was primarily due to large decreases in two subjects with high preexercise Rrs values. Neither pre- nor postexercise Rrs was correlated with the exercise A-aDO2, PaO2, or PaCO2; however, there was a trend for an increase in Rrs after exercise to be related to a wide A-aDO2 (r = 0.42; P = 0.096) and low PaO2 (r -0.41; P = 0.105). It was not related to differences in PaCO2. The frequency dependence of Rrs was also not affected by exercise and did not correlate with exercise blood-gas variables. Substituting helium for room air caused Rrs to fall by ~1 cmH2O · l-1 · s (at 5 Hz), and frequency dependence of Rrs tended to be greater (0.96 helium vs. 0.75 air), but this helium effect was not significant and also did not differ pre- to postexercise. None of the lung volumes, maximal flow rates, or DLCO changed significantly pre- to postexercise (see Table 2).

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Pre- and postexercise lung function

Baseline FEV1 (%predicted) was correlated to nadir exercise SaO2 (r = 0.567; P = 0.018) and to PaO2 (r = 0.589; P = 0.013). The slope of the N2 washout was inversely correlated to exercise SaO2 (r = -0.736; P = 0.002) and positively with A-aDO2 (r = 0.550; P = 0.034). VC (%predicted) was negatively associated with the A-aDO2 (r = -0.485; P = 0.048), and forced VC (%predicted) with PaO2 (r = 0.511; P = 0.036). No other resting lung function measures correlated with the degree of hypoxemia.

Airway reactivity to methacholine. Individual values for FEV1, Rrs, and IC during the MCT are presented in Fig. 8. With the use of the clinical definition of the concentration of methacholine causing a 20% fall in FEV1 (PC20), 2 of 16 subjects would be classified as having a positive MCT (PC20 < 4 mg/ml), and three additional subjects would be considered to have borderline bronchial hyperresponsiveness (PC20 = 4-16 mg/ml). The rest had normal bronchial responsiveness (PC20 > 16 mg/ml). We also calculated 95% confidence intervals for both Rrs and FEV1 values in each subject based on repeated baseline measurements conducted on the various test days (n = 4-12 values). We then determined the dose of methacholine that caused a significant change in Rrs or FEV1 (i.e., one that exceeded the 95% confidence interval). Seven subjects had a measurable change in Rrs before (at a lower dose) FEV1 changed; in four, Rrs and FEV1 changed at the same dose; and in five, FEV1 changed at a lower dose. Rrs of 5-25 Hz changed in response to the MCT in a similar manner across subjects as did Rrs at 5 Hz.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 8.   Effects of methacholine challenge testing on forced expiratory volume in 1 s (FEV1; A), total respiratory resistance (Rrs) at 5 Hz (B), and inspiratory capacity (IC; C) for each subject. The methacholine challenge test was ended if FEV1 fell by >= 20% or a dose of 32 mg/ml was reached. Each individual is represented by a different symbol. Subjects in Lo-PO2 group are identified by connecting solid lines and those in Hi-PO2 by dotted lines.

A fall in IC was related to the increase in Rrs. IC decreased from 2.41 ± 0.51 liters at baseline to 2.12 ± 0.46 liters after the final methacholine dose; it also decreased to a greater extent in those subjects who had a positive or borderline response to the methacholine (decrease of 23 ± 11% from baseline to final dose compared with a decrease of 8 ± 7% in the subjects with a normal response). Constant-flow expiratory NO concentration did not change in response to any dose of methacholine.

Response to methacholine did not predict EIAH. There was no relationship between the percent decline in FEV1 or increase in Rrs at 5 Hz during the MCT and exercise PaO2 or A-aDO2 (r <=  0.1, P > 0.6). In addition, exercise-induced changes in Rrs and FEV1 were not related to bronchial hyperresponsiveness to methacholine in our group of subjects. Five subjects had a >1 cmH2O · l-1 · s increase in Rrs at a methacholine dose of 4 mg/ml; in these same subjects, the change in Rrs pre- to postexercise was a fall of between 0.3 and 2.0 cmH2O · l-1 · s.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The purpose of this study was to determine the time course of SaO2 and gas exchange during prolonged, constant work rate, high-intensity running exercise to exhaustion and to evaluate baseline and changes in pre- to postexercise lung function, including airway resistance, in relation to EIAH. At the first minute of exercise, PaO2 fell 14 Torr from rest and A-aDO2 widened to 27 Torr; at the same time, PaCO2 was nearly unchanged from rest. After the initial fall, PaO2 rose slightly as PAO2 increased with the onset of hyperventilation, and there was no further worsening of pulmonary gas exchange (as evidenced by a constant A-aDO2) over the exercise time. SaO2 continued to fall throughout the exercise bout, indicating the importance of a time-related decrease in pH and increasing temperature at any given PaO2. Changes in large or small airway function with exercise and airway responsiveness to methacholine were not related to the development or degree of EIAH or gas exchange impairment. This lack of correlation existed despite the fact that several subjects had high baseline airway resistance and/or bronchial hyperresponsiveness to methacholine.

Comparison with previous "prolonged" constant-workload studies. Many studies have examined EIAH by using an incremental exercise protocol or very short-term heavy exercise; however, there have been relatively few studies that have examined the time course of EIAH or gas exchange during a constant-workload exercise bout lasting >5 min, and none of these has been conducted with female subjects. The studies that have been done were conducted at lower intensities and over a longer exercise time than the present study (17, 20, 46, 48). In each of these studies, arterial desaturation was generally absent as PaO2 did not fall >5 Torr on initiation of exercise and typically rose slightly across the exercise time, whereas A-aDO2 ranged between 10 and 25 Torr, and in only one of the studies (48) did it worsen over time. Interestingly, most of the subjects in the Dempsey et al. study (13) who showed no EIAH during long-term, moderate-intensity exercise did desaturate significantly during short-term maximal exercise. In the present study, high-intensity, prolonged exercise elicited significant gas exchange impairment and EIAH in approximately one-half of the subjects.

Relative contributions of PaO2, pH, and temperature to the fall in SaO2. The fall in PaO2 that occurred in the rest-to-exercise transition accounted for the majority of the decreased SaO2 early in the exercise bout. However, in most subjects, PaO2 then rose slightly over the course of exercise, and the further fall in SaO2 was completely due to decreasing pH and increasing temperature and the resultant rightward shift of the Hb-O2 dissociation curve.

Individual variations in temperature, pH, and PaO2 can greatly affect SaO2. Esophageal temperature increased to >= 39°C in all subjects and in two reached >= 40.0°C at exhaustion. This temperature increase is higher than what is typically seen during an incremental exercise test (38.2°C in Ref. 18) and is likely the result of a greater amount of time spent near maximal effort. Changes in the pH of arterial blood were more varied, falling only slightly in some and to <7.20 in several others. What is the effect of differences in pH and temperature in subjects with similar PaO2 and A-aDO2 values on SaO2? Two subjects maintained an A-aDO2 of ~28 Torr and a PaO2 of ~80 Torr, but their pH fell to <= 7.20 and body temperature rose to 40°C. In these subjects, SaO2 decreased to <= 90% at exhaustion. In contrast, two other subjects with a wider A-aDO2 (~34 Torr) and a lower PaO2 (~77 Torr), but whose pH remained >7.33 and temperature rose to only 39.5°C, had an SaO2 at end exercise of 93-94%. Thus, whereas PaO2 remains the primary determinant of SaO2, the influence of individual differences in changes in pH and body temperature during exercise and the importance of changes in these variables over exercise time should not be overlooked. The effects of pH on desaturation in rowers during high-intensity exercise have been stressed previously (32).

Correlation of EIAH with resting lung function. Our resting spirometry values were within normal ranges. DLCO was slightly below predicted values based on equations by Knudson et al. (24) and also by Crapo and Morris (11). The absolute values for DLCO and for DLCO/VA of our female subjects were nearly identical to those found in similar groups of fit female subjects (18, 19).

Hopkins et al. (20) found that the development of VA/Q inequality during exercise (as measured by the log SD of Q distribution during the multiple inert-gas elimination technique) was significantly correlated with the ratio of TLC to BSA (TLC/BSA) and hypothesized that perhaps people with a smaller relative lung size would have smaller airways and blood vessels and that this could accentuate any regional inhomogeneities in the distribution of air and blood flow (20). We found no relationship between A-aDO2 and TLC/BSA (r = 0.166; P = 0.525), nor was a relationship found in the study by Harms et al. (18), which included 29 female subjects with a wide range of EIAH at VO2 max. Despite this, in the present study, several other measures of lung size or function (VC, FVC, and FEV1) were weakly (r < 0.6; see RESULTS), but significantly, correlated with the A-aDO2 or PaO2 during exercise. Therefore, it is unclear what, if any, role lung size has in explaining EIAH in healthy subjects. We emphasize that a lack of correlation between lung size and EIAH does not contradict the positive correlation reported of lung size to exercise VA/Q uniformity, because overall mean VA/Q rises substantially during exercise, thereby negating much of the effect of VA/Q nonuniformity on arterial oxygenation.

Airways and EIAH. Our rationale for studying the role of small airway reactivity and small airway resistance in EIAH was threefold. First, we reasoned that VA/Q maldistribution was a potential contributor to the widened A-aDO2 in persons with EIAH because, in both fit men (13, 41) and especially in female subjects (18), an excessive A-aDO2 was already obvious, even in mild-to-moderate-intensity exercise. These changes are unlikely to be attributable to diffusion limitation at these lower metabolic requirements; however, we wish to emphasize that diffusion limitation is a very likely contributor to EIAH and excessive A-aDO2 during high-intensity and maximal exercise intensities (41). Second, a recent study using pharmacological blockade also pointed to airway inflammation as a potential cause of the widened A-aDO2 in EIAH, at least in older, fit subjects (38). Thus airway resistance changes may be involved. However, in normal subjects, tests of large airway resistance, namely the expiratory flow-volume loop or FEV1, show no effect of maximum exercise; in fact bronchodilation is most often observed both during and after exercise (8), even in the presence of severe EIAH (23). Therefore, we reasoned that small or peripheral airway diameters might be compromised with heavy exercise, thereby creating a maldistribution of mechanical time constants and of inspired ventilation (26). Finally, we also suspected that even relatively small increases in airway resistance may be especially important in women who, in general, have smaller airway diameters and lung volumes relative to men of similar age and stature (4, 29). This hypothesis was tested by using the forced oscillation technique to measure Rrs under physiological conditions with tidal breathing. The frequency dependence of Rrs (5-25 Hz) has been shown to be sensitive to selective increases in small airway resistance and to correlate highly with frequency dependence of compliance, especially when He-O2 is used as an inspirate (9). Change in the phase III of the single-breath N2 test was also used to document any exercise-induced changes in the distribution of inspired gas (10). On the other hand, there are several limitations to these methods. These tests were conducted postexercise, and, therefore, any changes apparent during exercise may have resolved in the recovering, resting subjects.

Our findings did reveal several subjects with abnormally elevated baseline Rrs and/or frequency dependence of Rrs, steep slopes of the phase III single-breath N2 test, and abnormal airway reactivity. Nonetheless, the findings were also consistent in demonstrating that exhaustive, prolonged exercise per se had no measurable deleterious effect on large or small airway function in any subject, nor was the absolute level of airway resistance or airway reactivity a significant determinant of the exercise-induced widening of the A-aDO2 or of EIAH.

We consider these mostly negative data concerning the relationships of airway resistance to EIAH as follows. For the high baseline Rrs subjects, it is feasible that these airway resistances were simply not sufficiently elevated to cause enough maldistribution of mechanical time constants to effect distribution of ventilation. Alternatively, moderate-to-heavy-intensity exercise with augmented tidal volumes will promote bronchodilation because of the tethering effects of the increased traction created by parenchymal attachments to the airway (44). Indeed, this lung-to-airway mechanical interaction at high tidal volume has also recently been shown to reduce the force generation by activated airway smooth muscle (16), and exercise-induced bronchodilation also occurs conversely secondary to a changing neurochemical control of bronchiolar smooth muscle (8). Furthermore, increases in inspiratory flow rate have been shown to elicit a more uniform topographical distribution of ventilation (5), and this influence may have been sufficient during heavy exercise, when peak flow rates increase 10 times or more and tidal volume is four to five times higher than at rest, to overcome these interindividual differences in Rrs. Certainly, the lack of exercise-induced increases in frequency dependence of Rrs may also reflect our inability with an indirect measurement to detect differences in the "silent zone" of the lung periphery until a very large number of these peripheral airways are compromised (9, 26).

MCT. Five of sixteen subjects had a positive MCT or were classified with borderline hyperresponsiveness. These responses to methacholine, whether measured in terms of Rrs or FEV1, did not correlate with changes in Rrs or FEV1 that occurred pre- to postexercise. In addition, the bronchoconstriction associated with the MCT did not correlate with the amount of hypoxemia present during exercise. As none of our subjects had any significant amount of bronchoconstriction (measured either with Rrs or FEV1) after exercise, this lack of correlation is not surprising. The finding that subjects with hyperreactive airways did not respond to exercise in a similar manner as they did to methacholine has also been reported by others (1) and may reflect the fact that even exhaustive exercise (at least in the nonasthmatic subject) does not involve sufficient bronchoprovocation via release of inflammatory mediators to cause measurable changes in central or peripheral airway diameter.

Histamine and EIAH. Histamine is an inflammatory mediator that can induce airway bronchoconstriction via effects on smooth muscle but also is known to increase vascular permeability (7). Plasma histamine has also been found to be significantly higher in athletes compared with sedentary controls at the end of a maximal exercise bout (2). Furthermore, a significant correlation between histamine release (%H = plasma histamine as a percentage of whole blood histamine) and the degree of hypoxemia implicates a possible role for this inflammatory mediator in the exercise-induced fall in PaO2 (2, 31). Because histamine in the circulation likely reflects basophil release to a much greater extent than lung mast cell release, is complicated by a very short half-life, and is possibly released during centrifugation, it is unclear whether histamine is causal or only indirectly related to EIAH (7, 22, 30, 39).

In our subjects, mean plasma histamine concentration increased with time over the course of the constant work rate exercise bout, and the absolute concentration and change from rest was similar (2) or slightly higher (31) at exhaustion to values found in athletes at the end of an incremental maximal exercise test. In contrast to previous studies, subjects in the present study with the greatest amount of hypoxemia tended to have a lower, not higher, plasma histamine concentration (see Fig. 5, C and D). A confounding factor may be differences in subject selection; all subjects in the present study were athletes of comparable fitness levels, whereas Anselme et al. (2) compared highly trained athletes with sedentary subjects. Thus the corresponding work rates (and potentially other factors such as time of exercise, body temperature, pH, etc.) at maximal exercise were different between those two groups. Both previous studies did find significant correlations with the change in %H from rest to maximal exercise and the drop in PaO2 in their highly trained athletes. The meaning of %H is unclear as changes in %H from rest to maximal exercise are primarily due to changes in plasma histamine because whole blood histamine remains relatively unchanged (31) or increases during exercise (2). Furthermore, %H remained unchanged across exercise intensities of 50-100% of VO2 max (31). Given this, it is unclear why %H correlates with EIAH. Perhaps %H is simply a marker for "leaky basophils," which in turn is correlated with an increased permeability of the pulmonary vasculature. The association between a reduction in %H and a reduction in the widening of the A-aDO2 and fall in PaO2 during exercise with the administration of nedocromil sodium provides indirect evidence for at least a partial causative role for histamine in EIAH (38); however, other possibilities exist. Because nedocromil sodium acts as a general mast cell stabilizer, it does not only block histamine release. Reduction of other potential inflammatory mediators (e.g., leukotrienes or prostaglandins) could have been responsible for the improvement in EIAH.

Finally, the findings of the present study show a rapid widening of the A-aDO2 immediately on onset of high-intensity exercise, with no further widening over the remaining exercise time to exhaustion. These data cast doubt on an inflammatory mechanism for EIAH simply because of the speed and stability of the occurrence of EIAH. Certainly, the role of histamine or other inflammatory mediators in EIAH remains in question, at least those mediators whose release would be influenced by increased flow and shear rates in both the airways and the pulmonary vasculature.

In summary, we demonstrated that continuing, high-intensity exercise, beyond the initial few minutes, has little further effect on gas exchange and that a continued fall in SaO2 is due to the combined effects of decreasing pH and increasing body temperature. We also confirmed that subjects with the greatest degree of EIAH during high-intensity exercise begin to show significant gas exchange abnormalities even during moderate-intensity exercise. We found that several of these fit subjects had high baseline airway resistance and hyperreactive airway responses to bronchoprovocation; however, airway resistance or its frequency dependence was not increased by prolonged, high-intensity exercise, nor was EIAH correlated with airway resistance or its reactivity. The reason why gas exchange impairment during exercise occurs in some subjects remains unanswered; whatever the cause, it becomes apparent early during high-intensity exercise and does not worsen over time.


    ACKNOWLEDGEMENTS

We thank our subjects for enthusiastic participation in this study. Special thanks to Matt O'Brien for technical assistance with methacholine dosing, Dr. Keith Meyer for medical assistance, and Zhuzai Xiang for analysis of histamine samples.


    FOOTNOTES

Support for this project was provided by National Heart, Lung, and Blood Institute (NHLBI) Grant RO1 HL-15469 and jointly by the US Departments of Veterans Affairs and Defense. T. J. Wetter was supported by a NHLBI training grant.

Address for reprint requests and other correspondence: T. J. Wetter, PO Box 53056, Medford, MA 02153 (E-mail: tjwetter{at}yahoo.com).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 18 December 2000; accepted in final form 10 April 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Anderson, SD, and Holzer K. Exercise-induced asthma: is it the right diagnosis in elite athletes? J Allergy Clin Immunol 106: 419-428, 2000[Web of Science][Medline].

2.   Anselme, F, Caillaud C, Couret I, Rossi M, and Prefaut C. Histamine and exercise-induced hypoxemia in highly trained athletes. J Appl Physiol 76: 127-132, 1994[Abstract/Free Full Text].

3.   ATS. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 161: 309-329, 2000[Free Full Text].

4.   ATS. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144: 1202-1218, 1991[Web of Science][Medline].

5.   Bake, B, Wood L, Murphy B, Macklem PT, and Milic-Emili J. Effect of inspiratory flow rate on regional distribution of inspired gas. J Appl Physiol 37: 8-17, 1974[Free Full Text].

6.   Baldwin, E, Cournand A, Dickinson W, and Richards J. Pulmonary insufficiency. I. Physiological classification, clinical methods of analysis, standard values in normal subjects. Medicine 27: 243-278, 1948[Medline].

7.   Barnes, PJ. The effect of histamine on airway function. In: The Lung: Scientific Foundations (2nd ed.), edited by Crystal RG, West JB, et al. Philadelphia, PA: Lippincott-Raven, 1997, p. 1297-1306.

8.   Beck, KC. Control of airway function during and after exercise in asthmatics. Med Sci Sports Exerc 31: S4-S11, 1999[Web of Science][Medline].

9.   Bhansali, PV, Irvin CG, Dempsey JA, Bush R, and Webster JG. Human pulmonary resistance: effect of frequency and gas physical properties. J Appl Physiol 47: 161-168, 1979[Abstract/Free Full Text].

10.   Comroe, JH. Physiology of Respiration. Chicago, IL: Year Book Medical Publishers, 1974.

11.   Crapo, RO, and Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 123: 185-189, 1981[Web of Science][Medline].

12.   Crapo, RO, Morris AH, Clayton PD, and Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 18: 419-425, 1982[Web of Science][Medline].

13.   Dempsey, JA, Hanson PG, and Henderson KS. Exercise-induced arterial hypoxaemia in healthy human subjects at sea level. J Physiol (Lond) 355: 161-175, 1984[Abstract/Free Full Text].

14.   Dempsey, JA, and Wagner PD. Exercise-induced arterial hypoxemia. J Appl Physiol 87: 1997-2006, 1999[Abstract/Free Full Text].

15.   Drinkwater, BL, Horvath SM, and Wells CL. Aerobic power of females, ages 10-68. J Gerontol 30: 385-394, 1975[Abstract].

16.   Fredberg, JJ, Inouye D, Miller B, Nathan M, Jafari S, Raboudi SH, Butler JP, and Shore SA. Airway smooth muscle, tidal stretches, and dynamically determined contractile states. Am J Respir Crit Care Med 156: 1752-1759, 1997[Abstract/Free Full Text].

17.   Hanson, P, Claremont A, Dempsey JA, and Reddan W. Determinants and consequences of ventilatory responses to competitive endurance running. J Appl Physiol 52: 615-623, 1982[Abstract/Free Full Text].

18.   Harms, CA, McClaran SR, Nickele GA, Pegelow DF, Nelson WB, and Dempsey JA. Exercise-induced arterial hypoxaemia in healthy young women. J Physiol (Lond) 507: 619-628, 1998[Abstract/Free Full Text].

19.   Hopkins, SR, Barker RC, Brutsaert TD, Gavin TP, Entin P, Olfert IM, Veisel S, and Wagner PD. Pulmonary gas exchange during exercise in women: effects of exercise type and work increment. J Appl Physiol 89: 721-730, 2000[Abstract/Free Full Text].

20.   Hopkins, SR, Gavin TP, Siafakas NM, Haseler LJ, Olfert IM, Wagner H, and Wagner PD. Effect of prolonged, heavy exercise on pulmonary gas exchange in athletes. J Appl Physiol 85: 1523-1532, 1998[Abstract/Free Full Text].

21.   Hopkins, SR, and McKenzie DC. Hypoxic ventilatory response and arterial desaturation during heavy work. J Appl Physiol 67: 1119-1124, 1989[Abstract/Free Full Text].

22.   Ind, PW, Brown MJ, Lhoste FJM, MacQuin I, and Dollery CT. Concentration effect relationships of infused histamine in normal volunteers. Agents Actions 12: 12-15, 1982[Web of Science][Medline].

23.   Johnson, BD, Saupe KW, and Dempsey JA. Mechanical constraints on exercise hyperpnea in endurance athletes. J Appl Physiol 73: 874-886, 1992[Abstract/Free Full Text].

24.   Knudson, RJ, Kaltenborn WT, Knudson DE, and Burrows B. The single-breath carbon monoxide diffusing capacity. Am Rev Respir Dis 135: 805-811, 1987[Web of Science][Medline].

25.   Knudson, RJ, Lebowitz MD, Holberg CJ, and Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 127: 725-734, 1983[Web of Science][Medline].

26.   Macklem, PT. The physiology of small airways. Am J Respir Crit Care Med 157: S181-S183, 1998.

27.   McClaran, SR, Harms CA, Pegelow DF, and Dempsey JA. Smaller lungs in women affect exercise hyperpnea. J Appl Physiol 84: 1872-1881, 1998[Abstract/Free Full Text].

28.   McClaran, SR, Wetter TJ, Pegelow DF, and Dempsey JA. Role of expiratory flow limitation in determining lung volumes and ventilation during exercise. J Appl Physiol 86: 1357-1366, 1999[Abstract/Free Full Text].

29.   Mead, J. Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis 121: 339-342, 1980[Web of Science][Medline].

30.   Morgan, DJR, Moodley I, Phillips MJ, and Davies RJ. Plasma histamine in asthmatic and control subjects following exercise: influences of circulating basophils and different assay techniques. Thorax 38: 771-777, 1983[Abstract/Free Full Text].

31.   Mucci, P, Durand F, Lebel B, Bousquet J, and Prefaut C. Interleukins 1-beta, -8, and histamine increases in highly trained, exercising athletes. Med Sci Sports Exerc 32: 1094-1100, 2000[Web of Science][Medline].

32.   Nielsen, HB, Madsen P, Svendsen LB, Roach RC, and Secher NH. The influence of PaO2, pH and SaO2 on maximal oxygen uptake. Acta Physiol Scand 164: 89-97, 1998[Web of Science][Medline].

33.   Ogilvie, CM, Forster RE, Blakemore WS, and Morton JW. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 36: 1-17, 1957.

34.   Otis, AB. Quantitative relationships in steady-state gas exchange. In: Handbook of Physiology. Respiration. Washington, DC: Am. Physiol. Soc, 1964, sect. 3, vol. I, chapt. 27, p. 681-698.

35.   Peat, JK, Salome CM, Berry G, and Woolcock AJ. Relation of dose-response slope to respiratory symptoms and lung function in a population study of adults living in Busselton, West Australia. Am Rev Respir Dis 146: 860-865, 1992[Web of Science][Medline].

36.   Pennings, HJ, and Wouters EFM Effect of inhaled beclomethasone dipropionate on isocapnic hyperventilation with cold air in asthmatics, measured with forced oscillation technique. Eur Respir J 10: 665-671, 1997[Abstract].

37.   Powers, SK, Martin D, Cicale M, Collop N, Huang D, and Criswell D. Exercise-induced hypoxemia in athletes: role of inadequate hyperventilation. Eur J Appl Physiol 65: 37-42, 1992.

38.   Prefaut, C, Anselme-Poujol F, and Caillaud C. Inhibition of histamine release by nedocromil sodium reduces exercise-induced hypoxemia in master athletes. Med Sci Sports Exerc 29: 10-16, 1997[Web of Science][Medline].

39.   Prefaut, C, Durand F, Mucci P, and Caillaud C. Exercise-induced arterial hypoxaemia in athletes. Sports Med 30: 47-61, 2000[Web of Science][Medline].

40.   Rice, AJ, Scroop GC, Gore CJ, Thornton AT, Chapman MJ, Greville HW, Holmes MD, and Scicchitano R. Exercise-induced hypoxaemia in highly trained cyclists at 40% peak oxygen uptake. Eur J Appl Physiol 79: 353-359, 1999[Web of Science].

41.   Rice, AJ, Thorton AT, Gore CJ, Scroop GC, Greville HW, Wagner H, Wagner PD, and Hopkins SR. Pulmonary gas exchange during exercise in highly trained cyclists with arterial hypoxemia. J Appl Physiol 87: 1802-1812, 1999[Abstract/Free Full Text].

42.   Ruppel, G. Manual of Pulmonary Function Testing. St. Louis, MO: Mosby, 1986.

43.   Schmekel, B, and Smith H-J. The diagnostic capacity of forced oscillation and forced expiration techniques in identifying asthma by isocapnic hyperpnoea of cold air. Eur Respir J 10: 2243-2249, 1997[Abstract].

44.   Skloot, G, Permutt S, and Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest 96: 2393-2403, 1995.

45.   St. Croix, CM, Wetter TJ, Pegelow DF, Meyer KC, and Dempsey JA. Assessment of nitric oxide formation during exercise. Am J Respir Crit Care Med 159: 1125-1133, 1999[Abstract/Free Full Text].

46.   Thomson, JM, Dempsey JA, Chosy LW, Shahidi NT, and Reddan WG. Oxygen transport and oxyhemoglobin dissociation during prolonged muscular work. J Appl Physiol 37: 658-664, 1974[Free Full Text].

47.   Trigg, CJ, Bennett JB, Tooley M, Sibbald B, D'Souza MF, and Davies RJ. A general practice based survey of bronchial hyperresponsiveness and its relation to symptoms, sex, age, atopy and smoking. Thorax 45: 866-872, 1990[Abstract/Free Full Text].

48.   Wasserman, K, Van Kessel AL, and Burton GG. Interaction of physiological mechanisms during exercise. J Appl Physiol 22: 71-85, 1967[Free Full Text].


J APPL PHYSIOL 91(2):847-858
8750-7587/01 $5.00 Copyright © 2001 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Romer, H. C. Haverkamp, A. T. Lovering, D. F. Pegelow, and J. A. Dempsey
Effect of exercise-induced arterial hypoxemia on quadriceps muscle fatigue in healthy humans
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2006; 290(2): R365 - R375.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. C. Haverkamp, J. A. Dempsey, J. D. Miller, L. M. Romer, D. F. Pegelow, J. R. Rodman, and M. W. Eldridge
Gas exchange during exercise in habitually active asthmatic subjects
J Appl Physiol, November 1, 2005; 99(5): 1938 - 1950.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. W. Eldridge, J. A. Dempsey, H. C. Haverkamp, A. T. Lovering, and J. S. Hokanson
Exercise-induced intrapulmonary arteriovenous shunting in healthy humans
J Appl Physiol, September 1, 2004; 97(3): 797 - 805.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Manohar, T. E. Goetz, and A. S. Hassan
NaHCO3 does not affect arterial O2 tension but attenuates desaturation of hemoglobin in maximally exercising Thoroughbreds
J Appl Physiol, April 1, 2004; 96(4): 1349 - 1356.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Manohar, T. E. Goetz, and A. S. Hassan
Preexercise hypervolemia does not affect arterial hypoxemia in Thoroughbreds performing short-term high-intensity exercise
J Appl Physiol, June 1, 2003; 94(6): 2135 - 2144.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Manohar, T. E. Goetz, A. S. Hassan, T. Depuy, and S. Humphrey
Anti-inflammatory agent, dexamethasone, does not affect exercise-induced arterial hypoxemia in Thoroughbreds
J Appl Physiol, July 1, 2002; 93(1): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
T. J. Wetter, Z. Xiang, D. A. Sonetti, H. C. Haverkamp, A. J. Rice, A. A. Abbasi, K. C. Meyer, and J. A. Dempsey
Role of lung inflammatory mediators as a cause of exercise-induced arterial hypoxemia in young athletes
J Appl Physiol, July 1, 2002; 93(1): 116 - 126.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. Aguilaniu, P. Flore, J. Maitre, J. Ochier, J. R. Lacour, and H. Perrault
Early onset of pulmonary gas exchange disturbance during progressive exercise in healthy active men
J Appl Physiol, May 1, 2002; 92(5): 1879 - 1884.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Manohar, T. E. Goetz, S. Humphrey, and T. Depuy
H1-receptor antagonist, tripelennamine, does not affect arterial hypoxemia in exercising Thoroughbreds
J Appl Physiol, April 1, 2002; 92(4): 1515 - 1523.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wetter, T. J.
Right arrow Articles by Dempsey, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wetter, T. J.
Right arrow Articles by Dempsey, J. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online